Behind the pathogenesis of osteoporosis and cardiovascular diseases

Archives of Medical Science

Volumn 7, Issue 4, 2011, Pages 568-569

  Salari, Pooneh ^a   Abdollahi, Mohammad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; OSTEOCLAST DIFFERENTIATION FACTOR;

ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; BONE DENSITY; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; EDITORIAL; LIPID METABOLISM; OSTEOPENIA; OSTEOPOROSIS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

EID: 80052563090     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.24121     Document Type: Editorial

References (18)

1. Boukhris R, Becker KL. Calcification of the aorta and osteoporosis. A roentgenographic study. JAMA 1972; 219: 1307-11.
2. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcify Tissue Int 1996; 59: 352-6.
3. Aronow WS. Osteoporosis, osteopenia and atherosclerosis vascular disease. Arch Med Sci 2011; 7: 21-6.
4. Seo SK, Cho S, Kim HY, et al. Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women. Menopause 2009; 16: 937-43.
5. Von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999; 106: 273-8.
6. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res 1997; 12: 283-9.
7. Salari Sharif P, Abdollahi M. A systematic review on the relationship between use of statins and osteoporosis. Int J Pharmacol 2011; 7: 180-8.
8. Yazici S, Yaziki M, Korkmaz U, et al. Relationship between blood pressure levels and bone mineral density in postmenopausal Turkish women. Arch Med Sci 2011; 7: 264-70.
9. Salari P, Abdollahi M. A comprehensive review of the shared roles of inflammatory cytokines in osteoporosis and cardiovascular diseases as two common old people problems; actions toward development of new drugs. Int J Pharmacol 2011; 7: 552-67.
10. Stojanovic O, Lazovic M, Lazovic M, Vuceljic M. Association between atherosclerosis the role of vitamin D. Arch Med Sci 2011; 7: 179-88.
11. Salari P, Abdollahi M. Controversial effects of non-steroidal anti-inflammatory drugs on bone: a review. Inflamm Allergy Drug Targets 2009; 8: 169-75.
12. Salari P, Rezaie A, Larijani B, Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit 2008; 14: RA37-44.
13. Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age 2010; 32: 179-86.
14. Salari P, Larijani B, Abdollahi M. Association of hyperhomocysteinemia with osteoporosis: a systematic review. Therapy 2008; 5: 215-22.
15. Salari Sharif P, Abdollahi M. The role of platelets in bone remodeling. Inflamm Allergy Drug Target 2010; 9: 393-9.
16. Salari Sharif P, Abdollahi M. A systematic review on the relationship between beta-blockers and bone health. Int J Pharmacol 2010; 6: 577-83.
17. Salama HM, El-Dayem SA, Yousef H, Fawzy A, Abou-Ismail L, El-lebedy D. The effects of L-thyroxin replacement therapy on bone minerals and body composition in hypothyroid children. Arch Med Sci 2010; 6: 407-13.
18. Kandil ME, Mourad A, Hamshary AE, Hussein G, Ah med A, Mawgoud SA. Evaluation of bone mineral density and bone turnover markers in Egyptian children with juvenile rheumatoid arthritis. Arch Med Sci 2009; 5: 434-42.